See the Glossary for more terms.
Due to technical difficulties, we have not been able to publish new content for more than a week, causing this issue to be delayed. We regret any inconvenience to you.
Today we posted our R01 interim NIAID Payline at the 8 percentile. Interim paylines are temporary administrative measures used to fund top-scoring applications early in the fiscal year.
After we get our annual appropriation, we will determine our actual paylines. Meanwhile, during this period at the start of the fiscal year, which begins on October 1, we expect to post additional interim paylines for several weeks or even months.
To give you an edge in these times of budget cuts, we created a new grantsmanship resource: the Strategy for NIH Funding.
It has features you'll appreciate, like sound advice and cold hard facts. But more importantly, it weaves the two together to provide a strategic approach—complete with action items and timing information—for every step of the application and grant.
That means the Strategy covers a lot of important ground, from how to qualify for an NIH grant to how to stay funded. And thanks to a unique layout, it gives you what you need to "get the job done" at whatever stage you're at.
All the Strategy's seven parts (except Part 1) comprise timing, strategy, and resource pages, which you can follow in that order to reap the full benefits. For your stage:
Along the way, you can check that your bases are covered with to do's to keep you abreast of critical action items and checkpoints to make sure you haven't overlooked any essential points. To learn more about the Strategy, including other features, read Start Here to Use the Strategy for NIH Funding.
As we did with our NIH Grant Cycle: Application to Renewal, which the Strategy replaces, we relied on the knowledge and experience of senior NIAID staff, including former NIH grantees, to create a resource you can refer to with confidence.
Due to the technical difficulties we are experiencing, you may still see links to the NIH Grant Cycle until our ability to post content is fully restored.
We hope you find the Strategy useful and welcome your comments. Email feedback to firstname.lastname@example.org.
No matter if you're a student or a seasoned scientist, virtually anyone can apply for Grand Challenges Explorations funding from the Bill and Melinda Gates Foundation.
Applications are due by November 17, 2011, on the following topics:
You can get $100,000 for the initial project, no preliminary data are required, and the application is only two pages. Sixty winners will be chosen in April, and successful Phase I grantees can compete for a Phase II grant of up to $1 million over two years.
Though this is not an NIAID opportunity, we thought our audience might be interested. Learn how to apply at Explorations Round 8 Now Open.
Take a look at our new Opportunities and Guidelines to Facilitate Scientific Collaborations portal.
On the site, you can find answers to commonly asked questions, learn how to use NIAID's facilities as a guest researcher or special volunteer, and read up on our various policies, regulations, and SOPs.
If you're confused about continuous submission—like what it is, how it works, and who's eligible—you'll be happy to hear about NIAID's new Continuous Submission questions and answers.
Be sure to check it out, and don't hesitate to email email@example.com with other questions you have about this and other topics on our Questions and Answers page.
Join the discussion of our plans for the Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases (RCE) by participating in a Town Hall meeting and Webinar on Tuesday, November 1, 2011.
Learn about research activities, accomplishments, and plans for the program's evolution. And if you'd like to suggest opportunities for improving the program, we would welcome those too.
To register and view the meeting agenda, visit National Institute of Allergy and Infectious Diseases (NIAID) Town Hall Meeting and Webinar on the Future of the NIAID Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases (RCE) Program.
To help us make sure we understand the latest state of the science as we plan future initiatives, please respond to our request for information on broad-spectrum antiviral agents that have therapeutic activity against more than one of the following viruses:
In your response, summarize your research and include the following information:
Your response should be no more than five pages, identify all proprietary information, and provide a primary contact name, address, email, and phone number. Your cover page, cover letter, and table of contents are not included in the page limit.
Please send your response or any questions to NIAIDcountermeasuresRFI@niaid.nih.gov by November 13, 2011. Read more in the September 14, 2011, Guide notice.
Here's some more important news from the NIH Guide.
Two Supplement FOAs Get New Expiration Date. NIH extended the expiration dates to September 30, 2012, which is good news for anyone planning to apply for these opportunities:
Review Your Grant RePORT. After FY 2011 comes to a close on September 30, confirm that staff in your business office check that your grant information is correct in NIH's public RePORT database. They have until October 7 to fix any errors. Read the September 16, 2011, Guide notice for details.
Take heed: Grants.gov will reject any application submitted by an institution with an expired Central Contractor Registration record.
Make sure your institution renews its registration annually and well before your receipt date because updates can take 24 hours or more to kick in.
Leaving room to breathe is important since NIH does not accept registration issues—including expired CCR records—as valid reasons for submitting an application late.
For more on registering with CCR, see the following:
Feel free to send us a question at firstname.lastname@example.org. After responding to you, we may include your question in the newsletter, incorporate it into the NIAID Research Funding site, or both.
"Can I apply for more than one K23 award or a K08 and K23 award at the same time?"—Rajesh Mohandas, University of Florida
No. NIH allows you to have only one career development application pending peer review at any time. That means you may not apply for two career development grants simultaneously or apply for a career development award while another career development application awaits review.
In the latter case, you have to wait until the review is complete or withdraw the first application before you can submit your next one.
For details, read the eligibility section of the appropriate funding opportunity announcement:
Go to Career Development Awards for information and advice.
"Does the amount of NIH funding an investigator receives have any bearing on his or her being nominated for an R56-Bridge award?"—Bethany Oates, Vanderbilt University
No, we do not consider your overall funding. We look at your application's relevance to our mission, its scientific merit, whether you're a new investigator, and whether you can accomplish meaningful results within one year. Read the NIAID R56-Bridge Award SOP for more.
View these and older announcements at NIAID Funding Opportunities List.
back to top
Last Updated September 30, 2011
Last Reviewed September 30, 2011